Sonire Therapeutics
Sonics brings new future to cancer patients
Tokyo, United States · Founded 2020 · $18.0M raised
- Headquarters
- Tokyo, California
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- sonire-therapeutics.com
- Total Funding
- $18.0M
- Last Round
- $18.0M Series AApr 2026
- Rounds
- 1
About
Sonire Therapeutics is developing a next-generation high-intensity focused ultrasound (HIFU) treatment system for unresectable pancreatic cancer. The company uses acoustic engineering to target tumors non-invasively and has received breakthrough device designation in Japan. It is conducting a randomized Phase 2 study of its HIFU therapy system.
Summary
Sonire Therapeutics is a Healthcare company based in Tokyo, United States, founded in 2020. It has raised $18.0M in total across 1 round, most recently a $18.0M Series A round in Apr 2026.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Similar Companies
operates in the healthcare industry focusing on biotechnology business
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Hyland provides content services and intelligent automation solutions for enterprises.
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...